Neuraxis (NRXS) director reports fund purchase of 286,138 shares

Rhea-AI Filing Summary

Neuraxis Inc. director Gil Aharon reported an indirect purchase of company stock. On 12/23/2025, an affiliate, Rosalind Master Fund L.P., purchased 286,138 common shares of Neuraxis at $3.52 per share, as disclosed in a Form 4 filing. The shares are held indirectly through Rosalind Advisors, Inc., which serves as advisor to Rosalind Master Fund L.P.

The filing notes that each reporting person disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest, meaning the economic exposure is limited to their financial stake in the fund rather than full ownership of all reported shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aharon Gil

(Last) (First) (Middle)

15 WELLESLEY STREET WEST

SUITE 326

(Street)

TORONTO A6 M4Y 0G7

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	12/23/2025		P		286,138(1)	A	$3.52	286,138	I	By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Rosalind Master Fund L.P. purchased 286,138 common shares at $3.52

2. Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.

	Gil Aharon	12/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Neuraxis (NRXS) disclose in this Form 4?

The filing reports that 286,138 Neuraxis common shares were purchased on 12/23/2025 at $3.52 per share by Rosalind Master Fund L.P., related to director Gil Aharon.

Who is the reporting person in the Neuraxis (NRXS) Form 4 filing?

The reporting person is Gil Aharon, who is identified in the filing as a director of Neuraxis Inc.

How many Neuraxis (NRXS) shares were acquired and at what price?

286,138 common shares of Neuraxis were acquired at a price of $3.52 per share, according to the Form 4.

Is the Neuraxis (NRXS) Form 4 transaction a direct or indirect holding?

The shares are reported as indirectly owned, held "By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.," rather than directly by Gil Aharon.

What does the beneficial ownership disclaimer mean in the Neuraxis (NRXS) Form 4?

The filing states that each reporting person disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest, indicating they claim ownership only to the degree of their economic interest.

Was the Neuraxis (NRXS) insider trade made under a Rule 10b5-1 plan?

The Form 4 includes a checkbox for transactions made under a Rule 10b5-1(c) trading plan, but the excerpt only shows the instruction text and does not indicate that the box was checked.